Cargando…

Molecular risk factors for locoregional recurrence in resected non‐small cell lung cancer

BACKGROUND: Locoregional recurrence is of high risk and is associated with a poor prognosis in terms of OS for non‐small cell lung cancer (NSCLC). Local control is essential for radical cure of NSCLC. Previous studies have investigated the clinicopathological risk factors for locoregional recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Wei, Zhang, Tao, Li, Runze, Chen, Xiaoxi, Pang, Jiaohui, Bao, Hua, Wu, Xue, Shao, Yang, Qiu, Bin, Gao, Shugeng, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417202/ https://www.ncbi.nlm.nih.gov/pubmed/37248810 http://dx.doi.org/10.1002/cam4.6165

Ejemplares similares

Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy
por: Fan, Chengcheng, et al.
Publicado: (2013)

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Qiu, Bin, et al.
Publicado: (2021)

Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020)

Locoregional recurrence via mucus-mediated extension following lung resection for mucinous tumors
por: Kawaguchi, Yo, et al.
Publicado: (2021)

Salvage proton beam therapy for locoregional recurrence of non-small cell lung cancer
por: Shin, Hyunju, et al.
Publicado: (2021)

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy
por: Ma, Li, et al.
Publicado: (2017)

Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed
por: Watanabe, Masanori, et al.
Publicado: (2012)

Efficacy of stereotactic body radiation therapy for locoregional recurrent pancreatic cancer after radical resection
por: Ji, Xiaoqin, et al.
Publicado: (2022)

Comparison of surgical difficulty in patients with resectable non-small cell lung cancer under different neoadjuvant treatment modes: a retrospective cohort study
por: Zhang, Fan, et al.
Publicado: (2021)

Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer
por: Hisakane, Kakeru, et al.
Publicado: (2017)

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
por: Sharon, Shay, et al.
Publicado: (2021)

Utility of endoscopic ultrasound for assessment of locoregional recurrence of pancreatic adenocarcinoma after surgical resection
por: Ragheb, Jonathan G., et al.
Publicado: (2023)

Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma
por: Park, Younghee, et al.
Publicado: (2023)

Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain
por: De Castro, Javier, et al.
Publicado: (2023)

The surgical management of early-stage lung adenocarcinoma: is wedge resection effective?
por: Ji, Ying, et al.
Publicado: (2021)

Multiple nodal locoregional recurrence of pheochromocytoma
por: Ramírez-Plaza, César Pablo, et al.
Publicado: (2015)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

Surgical Resection with Neoadjuvant Chemotherapy for Locoregionally Recurrent Appendiceal Cancer Invading the External Iliac Vessels
por: Takahashi, Jun, et al.
Publicado: (2018)

Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer
por: Kim, Eunji, et al.
Publicado: (2017)

Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy?
por: Wu, Xiao, et al.
Publicado: (2023)

Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2020)

Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study
por: Li, Qi-Wen, et al.
Publicado: (2020)

Case report: locoregional (perineum and inguinal) recurrence after treatment of rectal cancer by low anterior resection
por: Zhao, Rong, et al.
Publicado: (2013)

Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancer
por: NAKAMURA, RIEKO, et al.
Publicado: (2016)

Salvage radiation therapy for postoperative locoregionally recurrent non-small cell lung cancer: a single-center experience
por: Jo, Yoon Young, et al.
Publicado: (2021)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients
por: Zeng, Qingpeng, et al.
Publicado: (2021)

Impact of target area selection in (125) Iodine seed brachytherapy on locoregional recurrence in patients with non‐small cell lung cancer
por: Yan, Wei‐Liang, et al.
Publicado: (2017)

Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer
por: Shi, Wei, et al.
Publicado: (2019)

Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer
por: Yang, Wen-Chi, et al.
Publicado: (2020)

Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
por: Kheradmand, Ali Arab, et al.
Publicado: (2010)

Risk Factors of the Invasive Breast Cancer Locoregional Recurrence
por: Liubota, R. V., et al.
Publicado: (2015)

The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer
por: Kim, Tae Hyun, et al.
Publicado: (2010)

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
por: Liu, Hongjia, et al.
Publicado: (2023)

Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer
por: Guo, Wei, et al.
Publicado: (2019)

Chronic hyperglycemia is an adverse prognostic factor for locoregional recurrence‐free survival in small cell lung cancer patients treated with radical radiotherapy
por: Kong, Moonkyoo, et al.
Publicado: (2022)

Human monkeypox Italian locoregional small cluster
por: Bassi, Andrea, et al.
Publicado: (2022)

Feasibility of carbon‐ion radiotherapy for re‐irradiation of locoregionally recurrent, metastatic, or secondary lung tumors
por: Hayashi, Kazuhiko, et al.
Publicado: (2018)

A rare case of squamous cell carcinoma lung with multiple locoregional recurrences and histological transformation
por: Niwas, Ram, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f7u0a6i2d0lfumojdvoakbnlhn